News

Stay up to date on our latest stories.

Filters
Decorative image.

Hikma to host meet the management and site visit in Columbus, Ohio

Press Release, Corporate 17 March 2025
Hikma to host meet the management and site visit in Columbus, Ohio
Decorative image.
New

Hikma receives FDA approval and launches Mercaptopurine Oral Suspension in the US

Press Release, Product 27 February 2025
Hikma receives FDA approval and launches Mercaptopurine Oral Suspension in the US
Decorative image.
New

Strong 2024 performance and a positive outlook for 2025

Press Release, Financial Results 26 February 2025
Strong 2024 performance and a positive outlook for 2025
Decorative image.

Notice of results

Press Release, Financial Results 10 February 2025
Notice of results
Decorative image.

Hikma and M42 sign strategic MOU to advance healthcare innovation in the UAE

Press Release, Business Development 30 January 2025
Hikma and M42 sign strategic MOU to advance healthcare innovation in the UAE
Decorative image.

Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 m...

Press Release, Product 14 January 2025
Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 m...
Decorative image.

Hikma launches Meropenem for Injection, USP in the US

Press Release, Product 14 January 2025
Hikma launches Meropenem for Injection, USP in the US
Decorative image.

Hikma to present at 43rd Annual J.P. Morgan Healthcare Conference

Press Release, Corporate 13 January 2025
Hikma to present at 43rd Annual J.P. Morgan Healthcare Conference
Decorative image.

Hikma launches ePHEDrine Sulfate Injection, USP in the US

Press Release, Product 30 December 2024
Hikma launches ePHEDrine Sulfate Injection, USP in the US
Decorative image.
New

Hikma receives FDA approval and launches the generic version of Victoza®, Liraglutide, in the US

Press Release, Product 26 December 2024
Hikma receives FDA approval and launches the generic version of Victoza®, Liraglutide, in the US
Decorative image.

Hikma launches Indomethacin Suppositories in the US

Press Release, Product 20 December 2024
Hikma launches Indomethacin Suppositories in the US
Decorative image.
New

Hikma acquires the rights to a portfolio of Takeda brands for the MENA region

Press Release, Product 19 December 2024
Hikma acquires the rights to a portfolio of Takeda brands for the MENA region
Decorative image.
New

Hikma and Richter announce FDA submission acceptance for Denosumab biosimilar products

Press Release, Product 12 December 2024
Hikma and Richter announce FDA submission acceptance for Denosumab biosimilar products
Decorative image.
New

Hikma launches Furosemide Injection, USP, in the US

Press Release, Product 09 December 2024
Hikma launches Furosemide Injection, USP, in the US
Decorative image.

Sell-side analysts and investors visit Hikma Casablanca site

Press Release, Corporate 14 November 2024
Sell-side analysts and investors visit Hikma Casablanca site

You have viewed 15 of 462 results